FY20 new start-JW200215-improving neurotrauma by depolarization inhibition with combination therapy (indict): a phase 2 randomized trial

Ended Definitive Contract Awarded Last action

Contract number
W81XWH21C0075
Awardee
Awarding agency
Obligated
$4,427,503

Award facts

Contract value 100% obligated
$4,427,503.02 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Cost No Fee
Place of performance
Cincinnati, OH 45220, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Change Order P00004 · Improving neurotrauma by depolarization inhibition with combination therapy $0
Other Administrative Action P00003 $0
Supplemental Agreement for work within scope P00002 · Improving neurotrauma by deplarization inhibition with combination therapy (indict) PHASE2 randomized trial in support of the cdmrp $0
Other Administrative Action P00001 $0
Original award $4,427,503

About this award

This is a $4,427,503.02 definitive, cost-no-fee contract awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to the University of Cincinnati for the "Improving Neurotrauma by Depolarization Inhibition with Combination Therapy (INDICT): A Phase 2 Randomized Trial". The contract, which has a performance period through September 20, 2026, aims to improve treatments for neurotrauma through research and clinical trials. The University of Cincinnati is the prime contractor, with the University of California, San Francisco and the University of New Mexico serving as major subcontractors for specific aspects of the research. This contract is not designated as a set-aside. The Department of Defense's MEDCOM organization, which oversees medical research and healthcare for the U.S. military, is the funding agency for this project focused on advancing treatments for traumatic brain injuries and related neurological conditions.

Subawards

Subcontractor Amount Awarded
The Regents Of The University Of California. San Francisco IMPROVING NEUROTRAUMA BY DEPLARIZATION INHIBITION WITH COMBINATION THERAPY (INDICT) PHASE 2 RANDOMIZED TRIAL IN SUPPORT OF THE CDMRP. Improving Neurotrauma by… $357,454

Quick answers

Who was awarded contract W81XWH21C0075?

W81XWH21C0075 was awarded to Cincinnati Univ Of by Medical Command (Department of the Army) on September 21, 2021.

How much is contract W81XWH21C0075 worth?

The government has obligated $4,427,503 on W81XWH21C0075.

Was contract W81XWH21C0075 competed?

The extent of competition for W81XWH21C0075 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award